NP Life Sciences Health Industry Group Inc. (ACAT)

Every figure this model derived for ACAT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2023-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 70,614 CashAndCashEquivalentsAtCarryingValue 2023-12-31
current assets 278,542 AssetsCurrent 2019-09-30
current liabilities 38,121 LiabilitiesCurrent 2023-12-31
equity 16,381 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 2023-12-31
interest expense 645 InterestExpense 2023-12-31
ocf -73,607 NetCashProvidedByUsedInOperatingActivities 2023-12-31
revenue 164,621 RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up ACAT on one particular measure came for.

RatioValue
cash operating margin-0.42
current ratio9.91
current ratio reported7.31
dilution pct0.0
fcf margin-44.71
growth cv1.19
interest cover-1.07
operating margin-0.42
owner earnings margin-44.71
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about ACAT's figures. Written by the derivation as it ran, not added afterwards.